Saturday 17 October 2026
Export ISRG’s income statement to Excel — free account
Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.5%, EPS grew 25.5% and free cash flow grew 69.3%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for five consecutive years, operating cash flow growth for three.
426.70
1.16
−0.27%
Follow ISRG
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 6 | 7 | 7 |
+8 more TTM periods Free account |
| 17.32% | 17.12% | 16.57% | 16.79% | ||
| 15.30% | 15.15% | 14.57% | 14.81% | ||
ROIC |
16.49% | 15.40% | 15.33% | 14.51% | |
Return on Tangible Assets |
23.83% | 24.13% | 21.78% | 23.14% | |
Average Days of Receivables |
55.35 | 55.04 | 55.39 | 47.84 | |
Free Cash Flow per Share |
9.23 | 8.12 | 6.98 | 6.37 | |
Free Cash Flow |
3,268.60 | 2,880.30 | 2,490.70 | 2,271.30 | |
Capital Expenditures |
(437.80) | (480.50) | (539.80) | (689.30) | |
| Other line items | |||||
Cash ROIC |
13.90% | 13.02% | 10.43% | 10.35% | |
Accounts Receivable Turnover |
7.50 | 7.51 | 7.31 | 7.97 | |
Accounts Payable Turnover |
13.52 | 11.71 | 15.26 | 12.68 | |
Inventory Turnover |
1.99 | 2.04 | 2.06 | 1.98 | |
Average Days of Payables |
27.52 | 34.06 | 27.21 | 32.89 | |
Days of Inventory on Hand |
201.39 | 199.04 | 196.24 | 201.25 | |
Tax Rate |
(0.17) | (0.16) | (0.13) | (0.13) | |
Research and Development Expense of Revenue |
12.82% | 12.83% | 13.03% | 13.04% | |
Selling, General and Administrative Expense of Revenue |
22.58% | 23.01% | 23.70% | 24.04% | |
Share Based Compensation of Revenue |
7.49% | 7.68% | 7.83% | 7.93% | |
Operating CF/Net income |
1.18 | 1.13 | 1.06 | 1.08 | |
Depreciation/Fixed assets |
0.14 | 0.13 | 0.13 | 0.12 | |
Capex/Depreciation |
(0.55) | (0.65) | (0.80) | (1.11) | |
Revenue per Share |
31.16 | 29.82 | 28.20 | 26.95 | |
Operating CF per Share |
10.47 | 9.47 | 8.49 | 8.30 | |
Capex per Share |
(1.24) | (1.35) | (1.51) | (1.93) | |
Capex to Sales |
0.04 | 0.05 | 0.05 | 0.07 |
Columns are period end dates